Podcast

March 3, 2018

Podcast: This Week in Managed Care—Bipartisan Health Reform Outline and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Every week, The American Journal of Managed Care^® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care stories included a bipartisan group of governors releasing an outline for health reform; a report finds value-based contracts brings down prescription drug co-pays; 20 states file a lawsuit over the constitutionality of the Affordable Care Act.

Listen above or through one of these podcast services:

iTunes: http://apple.co/2eYWTss

TuneIn: http://bit.ly/2gv7iwj

Stitcher: http://bit.ly/2gCqtFg

Read more about the stories in this podcast:

Bipartisan Group of Governors Unveils Blueprint to Reform Health System

Value-Based Contracts Significantly Decrease Price of Co-Pays for Medications

Twenty States Allege ACA Is Unconstitutional in Federal Lawsuit

NCCN Releases Guidelines to Address Treatment Gaps for People With HIV and Cancer

Evidence-Based Oncology^® — Patient Centered Oncology Care 2017

Related Videos

Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center

Lynae Darbes, PhD

Bridgette Picou, LVN, ACLPN, The Well Project

Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth

Lynae Darbes, PhD

Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center

Cathy Eng, MD, FACP, FASCO

Annie Antar, MD, PhD, Johns Hopkins Medicine

Annie Antar, MD, PhD, Johns Hopkins Medicine

Related Content

AI technology | Image: Adobe Stock

April 17th 2025

Tech Updates: McKesson Launches Precision Oncology Consortium; Financing for RISA Labs PA Platform

These advances are designed to improve uptake of biomarker-driven cancer care and reduce treatment delays.

Managed Care Cast Thumbnail

April 15th 2025

Personalized Care Key as Tirzepatide Use Expands Rapidly

Maggie L. Shaw John W. Ostrominski, MD

Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.

IVBM Atlanta | Image credit: AJMC

April 14th 2025

Making Novel Cancer Therapies Available Requires Choices Because Resources Are Limited

Coverage from the Atlanta Regional meeting of the Institute for Value-Based Medicine.

February 25th 2025

Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care

Pearl Steinzor Arthur L. Jenkins III, MD, FACS

On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.

AJMC

April 4th 2025

Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage

Galen Shearn-Nance, BS Rishi R. Sachdev, BS Long Vu, MS Weichuan Dong, PhD Alberto J. Montero, MD, MBA Siran M. Koroukian, PhD Johnie Rose, MD, PhD

This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.

Money | Image credit: Stillfx - stock.adobe.com

April 3rd 2025

Freeze in International Funding Could Significantly Reverse Progress in HIV Treatment

Julia Bonavitacola

Countries located in sub-Saharan Africa would be most affected by all funding cuts to the international HIV response.

Related Content

AI technology | Image: Adobe Stock

April 17th 2025

Tech Updates: McKesson Launches Precision Oncology Consortium; Financing for RISA Labs PA Platform

These advances are designed to improve uptake of biomarker-driven cancer care and reduce treatment delays.

Managed Care Cast Thumbnail

April 15th 2025

Personalized Care Key as Tirzepatide Use Expands Rapidly

Maggie L. Shaw John W. Ostrominski, MD

Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.

IVBM Atlanta | Image credit: AJMC

April 14th 2025

Making Novel Cancer Therapies Available Requires Choices Because Resources Are Limited

Coverage from the Atlanta Regional meeting of the Institute for Value-Based Medicine.

February 25th 2025

Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care

Pearl Steinzor Arthur L. Jenkins III, MD, FACS

On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.

AJMC

April 4th 2025

Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage

Galen Shearn-Nance, BS Rishi R. Sachdev, BS Long Vu, MS Weichuan Dong, PhD Alberto J. Montero, MD, MBA Siran M. Koroukian, PhD Johnie Rose, MD, PhD

This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.

Money | Image credit: Stillfx - stock.adobe.com

April 3rd 2025

Freeze in International Funding Could Significantly Reverse Progress in HIV Treatment

Julia Bonavitacola

Countries located in sub-Saharan Africa would be most affected by all funding cuts to the international HIV response.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions